AstraZeneca Announces Record 15 Billion Dollar Investment in China Through 2030

AstraZeneca plans to invest 15 billion dollars in China by 2030 to boost manufacturing and research. The record commitment was announced in Beijing today.

Insights:
AstraZeneca plc announced on Jan 29, 2026, that it would invest $15 billion in China CNCNthrough 2030 to expand medicines manufacturing and research and development. The pharmaceutical company described this expansion as its largest-ever investment in China, representing a significant strategic commitment to its second-biggest market. This announcement was made during British Prime Minister Keir Starmer keir starmer's visit to Beijing as part of efforts by the United Kingdom GBGBto strengthen ties with the nation.
The National flag of China and the British Union Jack flutter next to the Tiananmen Gate, with a portrait of late Chinese Chairman Mao Zedong placed in the background, as British Prime Minister Keir Starmer visits Beijing, China, January 28, 2026. REUTERS/Maxim Shemetov
The National flag of China and the British Union Jack flutter next to the Tiananmen Gate, with a portrait of late Chinese Chairman Mao Zedong placed in the background, as British Prime Minister Keir Starmer visits Beijing, China, January 28, 2026. REUTERS/Maxim Shemetov